LLS is Committed to Advocating for Cancer Patients in Wake of Dobbs RulingPosted On: June 27, 2022 Read More
Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of LymphomaPosted On: June 24, 2022 Read More
America’s Youngest Generation is Trailblazing the Way for a Future without CancerPosted On: June 22, 2022 Read More
FDA Approves Immunotherapy for Aggressive Form of Follicular LymphomaPosted On: June 2, 2022 Read More
FDA Approves Combination Therapy for Patients with Certain Forms of Acute Myeloid LeukemiaPosted On: June 1, 2022 Read More
Please send all media-related inquiries and interview requests to firstname.lastname@example.org. An LLS representative will respond as soon as possible.